title: Influenza.
authors.affiliation: Cheshire and Merseyside Health Protection Team, Public Health England North West, Liverpool, UK sam.ghebrehewet@phe.gov.uk.
authors.forename: Sam
authors.initials: S
authors.lastname: Ghebrehewet
authors.affiliation: Cheshire and Merseyside Health Protection Team, Public Health England North West, Liverpool, UK.|Department of Public Health and Policy, The Farr Institute@HeRC, University of Liverpool, UK.|Department of Clinical Research, Liverpool School of Tropical Medicine, Liverpool, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: MacPherson
authors.affiliation: Department of Infectious Diseases, Queen Elizabeth University Hospital, Glasgow, UK.|Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
authors.forename: Antonia
authors.initials: A
authors.lastname: Ho
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D058872:Epidemics; D006760:Hospitalization; D006801:Humans; D017053:Infection Control; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D058873:Pandemics; D056990:Post-Exposure Prophylaxis; D018570:Risk Assessment
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines